Literature DB >> 6090842

Association of sequestered beta-adrenergic receptors with the plasma membrane: a novel mechanism for receptor down regulation.

C D Strader, D R Sibley, R J Lefkowitz.   

Abstract

Chronic exposure of frog erythrocytes to beta-adrenergic agonists leads to desensitization of the responsiveness of adenylate cyclase to isoproterenol and is accompanied by "down-regulation", a decrease in the number of beta-adrenergic receptors on the cell surface. When frog erythrocyte plasma membranes are prepared by osmotic lysis of cells, the receptors lost from the cell surface during desensitization can be recovered in a "light membrane fraction", obtained by centrifuging the cell cytosol at 158,000 X g for 1 hr. These receptors are sequestered away from the plasma membrane fraction which contains the adenylate cyclase and the guanine nucleotide regulatory protein. If desensitized frog erythrocytes are disrupted by gentler freeze/thaw procedures, however, the sequestered beta-adrenergic receptors can be demonstrated to be physically associated with the plasma membrane. Typically, plasma membranes prepared in this fashion do not demonstrate a significant down regulation despite attenuation of isoproterenol-stimulated adenylate cyclase activity. Under these conditions, beta-adrenergic receptors from control and desensitized preparations co-migrate on sucrose density gradients in exactly the same place as the plasma membrane marker, adenylate cyclase. In contrast, when membranes from osmotically lysed desensitized cells are fractionated on sucrose gradients the down regulated receptors are sequestered in a light membrane fraction which barely enters the gradient and which is physically separated from adenylate cyclase activity. The data are consistent with a novel mechanism of receptor down-regulation which appears to involve the sequestration of the beta-adrenergic receptors away from the cell surface into a membrane compartment which remains physically associated with the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090842     DOI: 10.1016/0024-3205(84)90359-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Localization of beta-adrenergic receptors in A431 cells in situ. Effect of chronic exposure to agonist.

Authors:  H Y Wang; M Berrios; C C Malbon
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

2.  Phosphorylation/dephosphorylation of the beta-adrenergic receptor regulates its functional coupling to adenylate cyclase and subcellular distribution.

Authors:  D R Sibley; R H Strasser; J L Benovic; K Daniel; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

3.  Gradient distribution pattern of muscarinic receptors in N1E 115 mouse neuroblastoma cells.

Authors:  N H Fraeyman; M A Buyse
Journal:  Experientia       Date:  1989-08-15

Review 4.  Beta-adrenergic receptor-coupled adenylate cyclase. Biochemical mechanisms of regulation.

Authors:  D R Sibley; R J Lefkowitz
Journal:  Mol Neurobiol       Date:  1987 Spring-Summer       Impact factor: 5.590

5.  Do agonists promote rapid internalization of beta-adrenergic receptors?

Authors:  L C Mahan; H J Motulsky; P A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

Review 6.  GPCR desensitization: Acute and prolonged phases.

Authors:  Sudarshan Rajagopal; Sudha K Shenoy
Journal:  Cell Signal       Date:  2017-01-28       Impact factor: 4.315

7.  Rapid and reversible desensitisation of vascular and platelet alpha 2 adrenoceptors.

Authors:  C A Hamilton; N M Deighton; J L Reid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

8.  Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell.

Authors:  B F Roettger; R U Rentsch; E M Hadac; E H Hellen; T P Burghardt; L J Miller
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.